menu

ReachMD

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Cord Blood: Emerging Clinical Applications

This activity highlights current and future applications for cord blood stem cells in the field of regenerative medicine.

Available credits: 0.25

Time to complete: 15 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Regenerative medicine is focused on the replacing or "regenerating" of human cells, tissues or organs, so as to restore or establish normal function. Cord blood stem cells are currently being researched for their regenerative utility for issues such as brain injury, hearing loss, autism, diabetes, and congenital heart disease. What are the current and future applications for cord blood in this field?

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty: 

    Karen E. Taylor, MD, FACOG
    Gynecology
    Newport Gynecology
    Newport, CA

    Charles S. Cox Jr., MD
    Professor of Pediatric Surgery
    UTHealth
    Houston, Texas

    Faculty’s disclosure

    Dr. Taylor receives consulting fees from Cord Blood Registry.

    Dr. Cox receives consulting fees from Cord Blood Registry, contracted research Cord Blood Registry, Athersys, Inc. and Biostage.  He has ownership in Emit and Coagulex.

    Reviewers/Planners/Authors:

    • Sean T. Barrett, has nothing to disclose.
    • Colleen Braun has nothing to disclose.
    • Barry A. Fiedel, PhD, has nothing to disclose.
    • Kia K. Gray, MPH has nothing to disclose.
    • Robert Schneider has nothing to disclose.
  • Target Audience

    This activity is designed to meet the educational needs of practicing obstetricians and gynecologists, maternal-fetal medicine specialists, nurses, nurse practitioners, certified nurse midwives, and physician assistants.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Appreciate the emerging science associated with cord blood transplantation
    • Evaluate the potential of regenerative medicine applications using cord blood stem cells
    • Assess the timeline for the emergence of potential of regenerative medicine clinical applications using cord blood stem cells 
  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education has a core focus on women's health and the ways in which diseases and conditions impact the female patient. That unique focus has transformed the CME learning environment for healthcare professionals nationwide. We impact thousands of clinicians annually, many of whom return each year for clinical updates and connectivity with regional peers.

    .

  • Commercial Support

    Supported by an independent educational grant from CBR, from AMAG Pharmaceuticals. 

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.